Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

CUSIP: 03237H101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
109,540,561
Total 13F shares
54,545,075
Share change
+3,184,647
Total reported value
$1,176,653,052
Put/Call ratio
32%
Price per share
$21.57
Number of holders
153
Value change
+$56,163,167
Number of buys
95
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q2 2023

As of 30 Jun 2023, Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,545,075 shares. The largest 10 holders included VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., VIKING GLOBAL INVESTORS LP, Boxer Capital, LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., Rock Springs Capital Management LP, and FEDERATED HERMES, INC.. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.